Angiopoietin inhibitors: A review on targeting tumor angiogenesis

2021/03/16 by Digna Parmar, Parmar Digna, Madhavi Apte · 27 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Angiogenesis and VEGF in Cancer #Hepatocellular Carcinoma Treatment and Prognosis #Cancer Mechanisms and Therapy

paper · doi:10.1016/j.ejphar.2021.174021

Cited by

• Rational design, expression and refolding of a novel bispecific antibody to simultaneously target VEGF-A and Ang-2 for inhibition of angiogenesis
• Angiogenic signaling pathways and anti-angiogenic therapy for cancer
• Ten years in the making: application of CrossMab technology for the development of therapeutic bispecific antibodies and antibody fusion proteins. [europepmc]
• Antiangiogenic Drugs in NASH: Evidence of a Possible New Therapeutic Approach. [europepmc]
• Distinct Clinical Impact and Biological Function of Angiopoietin and Angiopoietin-like Proteins in Human Breast Cancer. [europepmc]
• Natural Products: A Promising Therapeutics for Targeting Tumor Angiogenesis. [europepmc]
• Cancer cachexia: lessons from Drosophila. [europepmc]
• Angiogenesis, Lymphangiogenesis, and Inflammation in Chronic Obstructive Pulmonary Disease (COPD): Few Certainties and Many Outstanding Questions. [europepmc]
• The Regulatory Roles of Polysaccharides and Ferroptosis-Related Phytochemicals in Liver Diseases. [europepmc]
• Gastric Cancer-Derived Extracellular Vesicles (EVs) Promote Angiogenesis via Angiopoietin-2. [europepmc]
• Co-Targeting Tumor Angiogenesis and Immunosuppressive Tumor Microenvironment: A Perspective in Ethnopharmacology. [europepmc]
• Novel Drugs with High Efficacy against Tumor Angiogenesis. [europepmc]
• Ang2-Targeted Combination Therapy for Cancer Treatment. [europepmc]
• Design, Synthesis, Molecular Modeling, and Anticancer Evaluation of New VEGFR-2 Inhibitors Based on the Indolin-2-One Scaffold. [europepmc]
• Endothelial-Specific Molecule 1 Inhibition Lessens Productive Angiogenesis and Tumor Metastasis to Overcome Bevacizumab Resistance. [europepmc]
• The role of angiogenesis in melanoma: Clinical treatments and future expectations. [europepmc]
• Loss of TET2 impairs endothelial angiogenesis via downregulating STAT3 target genes. [europepmc]
• Advances in research of biological functions of Isthmin-1. [europepmc]
• Angiogenic signaling pathways and anti-angiogenic therapy for cancer. [europepmc]
• DCE-MRI-based radiomics in predicting angiopoietin-2 expression in hepatocellular carcinoma. [europepmc]
• Vascular normalization: reshaping the tumor microenvironment and augmenting antitumor immunity for ovarian cancer. [europepmc]
• Exploring the Spectrum of VEGF Inhibitors' Toxicities from Systemic to Intra-Vitreal Usage in Medical Practice. [europepmc]
• NRAS Q61R mutation drives elevated angiopoietin-2 expression in human endothelial cells and a genetic mouse model. [europepmc]
• Differential expression of angiogenesis-related genes 'VEGF' and 'angiopoietin-1' in metastatic and EMAST-positive colorectal cancer patients. [europepmc]
• Targeted anti-angiogenesis therapy for advanced osteosarcoma. [europepmc]
• Mesenchymal stem cells derived exosomes: a new era in cardiac regeneration. [europepmc]
• Dual role of miR-155 and exosomal miR-155 in tumor angiogenesis: implications for cancer progression and therapy. [europepmc]